Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder. (Q50307384)

2 March 2018

title

Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder. (English)

1 reference

2 March 2018

main subject

autism spectrum disorder

0 references

0 references

0 references

1 reference

0 references

3

1 reference

2 March 2018

author name string

Lv Wang

1

1 reference

2 March 2018

Claus Thagaard Christophersen

2

1 reference

2 March 2018

Jacobus Petrus Gerber

4

1 reference

2 March 2018

Manya Therese Angley

5

1 reference

2 March 2018

Michael Allan Conlon

6

1 reference

2 March 2018

publication date

26 April 2012

1 reference

2 March 2018

Digestive Diseases and Sciences

published in

1 reference

2 March 2018

volume

57

1 reference

2 March 2018

page(s)

2096-2102

1 reference

2 March 2018

issue

8

1 reference

2 March 2018

https://scigraph.springernature.com/pub.10.1007/s10620-012-2167-7

exact match

0 references

cites work

Genetic basis of autism: is there a way forward?

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Evaluation, Diagnosis, and Treatment of Gastrointestinal Disorders in Individuals With ASDs: A Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Is urinary indolyl-3-acryloylglycine a biomarker for autism with gastrointestinal symptoms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Pyrosequencing study of fecal microflora of autistic and control children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Influence of phenol, p-cresol and indole on growth and survival of intestinal lactic acid bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Are there more bowel symptoms in children with autism compared to normal children and children with other developmental and neurological disorders?: A case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Measurement of phenol and p-cresol in urine and feces using vacuum microdistillation and high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Bacterial population dynamics and faecal short-chain fatty acid (SCFA) concentrations in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Neurobiological effects of intraventricular propionic acid in rats: Possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Colonic health: fermentation and short chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Gut microflora associated characteristics in children with celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Human nutrition, the gut microbiome and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Abnormal intestinal permeability in children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Urinary levels of neopterin and biopterin in autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Gastrointestinal flora and gastrointestinal status in children with autism – comparisons to typical children and correlation with autism severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Relative carnitine deficiency in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

21 January 2018

Neurobiology of ammonia.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Urinary p-cresol is elevated in small children with severe autism spectrum disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Variation in human intestinal microbiota with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Bifidobacteria can protect from enteropathogenic infection through production of acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2167-7

Fecal Butyrate Levels Vary Widely among Individuals but Are Usually Increased by a Diet High in Resistant Starch

21 January 2018

1 reference

12 December 2020

Modified reagents for determination of urea and ammonia

1 reference

12 December 2020

Dietary intake and faecal excretion of carbohydrate by Australians: importance of achieving stool weights greater than 150 g to improve faecal markers relevant to colon cancer risk

1 reference

12 December 2020

The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease

1 reference

12 December 2020

Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides

1 reference

12 December 2020

10.1007/S10620-012-2167-7

Identifiers

DOI

1 reference

2 March 2018

PubMed ID

22535281

1 reference

2 March 2018